[A Case of Apocrine Carcinoma of the Breast with Complete Response to Chemotherapy for Local Recurrence after 13 Years of Surgery].

The patient is a 46-year-old woman who previously underwent a partial mastectomy with sentinel lymph node biopsy for a 5.6 cm diameter noninvasive breast apocrine carcinoma in the upper, inner quadrant right breast at age 33. Thirteen years later, a 2.1 cm diameter tumor appeared in the same area, and core needle biopsy examination revealed invasive apocrine carcinoma(ER[-], PR[-], HER2[+]). Without distant metastasis, the patient received doxorubicin plus cyclophosphamide( AC)therapy followed by trastuzumab, pertuzumab, docetaxel(HPD)therapy as neoadjuvant chemotherapy. Subseqently, the tumor disappeared clinically. Mastectomy was performed, and complete response was confirmed pathologically.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-01
Primary Topic
Breast Lesions and Carcinomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[A Case of Apocrine Carcinoma of the Breast with Complete Response to Chemotherapy for Local Recurrence after 13 Years of Surgery].

Jun Kaneko, Yasushi Takatsuno, Yasuhiro Higashi, Masaki Matsumura et al.
PubMed
Breast Lesions and Carcinomas
article

[A Case of Apocrine Carcinoma of the Breast with Complete Response to Chemotherapy for Local Recurrence after 13 Years of Surgery].

Jun Kaneko, Yasushi Takatsuno, Yasuhiro Higashi, Masaki Matsumura, Jun Isogai, T Hayakawa, Kumi Hasegawa
article en

Abstract

The patient is a 46-year-old woman who previously underwent a partial mastectomy with sentinel lymph node biopsy for a 5.6 cm diameter noninvasive breast apocrine carcinoma in the upper, inner quadrant right breast at age 33. Thirteen years later, a 2.1 cm diameter tumor appeared in the same area, and core needle biopsy examination revealed invasive apocrine carcinoma(ER[-], PR[-], HER2[+]). Without distant metastasis, the patient received doxorubicin plus cyclophosphamide( AC)therapy followed by trastuzumab, pertuzumab, docetaxel(HPD)therapy as neoadjuvant chemotherapy. Subseqently, the tumor disappeared clinically. Mastectomy was performed, and complete response was confirmed pathologically.

PubMedVol. 51(13)
Hakodate National Hospital (JP)
Openalex Percentile: Top 59%
Breast Lesions and Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.